BamSEC and AlphaSense Join Forces
Learn More

Accelerate Diagnostics Inc

OTC: AXDXQ    
Share price (6/5/25): $0.01    
Market cap (6/5/25): $252 thousand
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 79 pages Asset Purchase Agreement by and Between Accelerate Diagnostics, Inc., Accelerate Diagnostics Texas, LLC, and Indaba Starling, LLC Dated as of May 30, 2025
12/34/56
EX-10.1
from 8-K 18 pages Accelerate Diagnostics, Inc. – Stalking Horse Term Sheet
12/34/56
EX-10.5 4
from 10-K 5 pages Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan Notice of Grant of Nonqualified Stock Options
12/34/56
EX-10.5 3
from 10-K 6 pages Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan Notice of Grant of Restricted Stock Units
12/34/56
EX-10.3
from 8-K 58 pages Super-Priority Security Agreement Among Accelerate Diagnostics, Inc., as Issuer, and the Guarantors Party Hereto From Time to Time, as Guarantors and U.S. Bank Trust Company, National Association, as Collateral Agent Dated as of August 8, 2024
12/34/56
EX-10.1
from 8-K 34 pages Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 1 page Second Amendment to the Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan
12/34/56
EX-10.30
from 10-K 14 pages Material contract
12/34/56
EX-10.17
from 10-K 9 pages Attachment B Consulting Services Agreement
12/34/56
EX-10.1
from 8-K 23 pages Form of Subscription Agreement
12/34/56
EX-10.3
from 8-K 3 pages First Amendment to Note Exchange Agreement
12/34/56
EX-10.2
from 8-K 3 pages First Amendment to Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 4 pages First Amendment to Securities Purchase Agreement Accelerate Diagnostics, Inc. and Jack W. Schuler Living Trust
12/34/56
EX-10.8
from 8-K 12 pages Securities Purchase Agreement
12/34/56
EX-10.7
from 8-K 19 pages Amendment No. 1 to Securities Purchase Agreement
12/34/56
EX-10.6
from 8-K 4 pages Consent and Amendment No. 1 to Secured Promissory Note
12/34/56
EX-10.3
from 8-K 59 pages Security Agreement Among Accelerate Diagnostics, Inc., as Issuer, and the Guarantors Party Hereto From Time to Time, as Guarantors and U.S. Bank Trust Company, National Association, as Collateral Agent Dated as of June 9, 2023
12/34/56
EX-10.2
from 8-K 35 pages Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 44 pages Note Exchange Agreement
12/34/56
EX-10.1
from 8-K 1 page First Amendment to the Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan
12/34/56